Atezolizumab Plus Chemotherapy for First-Line Treatment of Nonsquamous NSCLC: Results From the Randomized Phase 3 IMpower132 Trial
2020 · Journal of Thoracic Oncology · 430 citations
https://doi.org/10.1016/j.jtho.2020.11.025
J
Jerome H. Goldschmidt
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
96
Papers
2.8K
Citations
21
h-index
33
i10-index
Jerome H. Goldschmidt is an academic researcher. The author has contributed to research in topics: Lung Cancer Treatments and Mutations & Cancer Immunotherapy and Biomarkers & Lung Cancer Research Studies. The author has an h-index of 21, co-authored 82 publications.
Papers by this author
worksSotatercept (ACE-011) for the treatment of chemotherapy-induced anemia in patients with metastatic breast cancer or advanced or metastatic solid tumors treated with platinum-based chemotherapeutic regimens: results from two phase 2 studies
2015 · Supportive Care in Cancer · 65 citations
https://doi.org/10.1007/s00520-015-2929-9
Real-World Outcomes of Trilaciclib Among Patients with Extensive-Stage Small Cell Lung Cancer Receiving Chemotherapy
2023 · Advances in Therapy · 6 citations
https://doi.org/10.1007/s12325-023-02601-2
Treatment Patterns and Clinical Outcomes Among Patients with Metastatic Non-small Cell Lung Cancer Without Actionable Genomic Alterations Previously Treated with Platinum-Based Chemotherapy and Immunotherapy
2024 · Drugs - Real World Outcomes · 1 citations
https://doi.org/10.1007/s40801-024-00440-3
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat